Bristol Myers Squibb shares fall as FDA delays action on can

Shares of Bristol Myers Squibb, 2seventy bio fell early Monday as FDA said it would miss a regulatory action date on a cancer treatment

Related Keywords

, Bristol Myers Squibb Co , Bristol Myers Squibb , Drug Administration , Myers Squibb , Article Normal , Biotechnology Services , Pharmaceuticals , Healthcare Life Sciences , Biopharmaceuticals , Regulation Government Policy , Financial Performance , Share Price Movement Disruptions , New Products Services , Product Service Approvals , Corporate Industrial News , Products Services , Cancer , Political General News , Health , Medical Conditions , Medical Treatments Procedures , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Bmy , 2seventy Bio Inc , Tsvt , Regulation , Government Policy , Share Price Movement , Disruptions , New Products , Services , Product , Service Approvals , Corporate , Industrial News , Products , Political , General News , Medical Treatments , Procedures , Commodity , Financial Market News , Healthcare , Life Sciences ,